VANESSA DEKEYZER: Open Payments
NPI 1366157455 · LAFAYETTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$535 in 23 payments from 10 companies in 2025. Trend: 2023 $181 · 2024 $358 · 2025 $535
Food & beverage: $535
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 4 | $115 |
| Axsome Therapeutics, Inc. | 3 | $91 |
| Janssen Pharmaceuticals, Inc | 4 | $71 |
| Teva Pharmaceuticals USA, Inc. | 2 | $68 |
| E.R. Squibb & Sons, L.L.C. | 3 | $56 |
| ABBVIE INC. | 2 | $47 |
| Neurocrine BioSciences, Inc. | 2 | $40 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
Products named: HETLIOZ, Auvelity, AUSTEDO XR, COBENFY, VRAYLAR, INGREZZA, SPRAVATO, INVEGA SUSTENNA.
Industry payments across IN — which companies pay providers there.
